Prudential Financial Inc Histogen Inc. Transaction History

Prudential Financial Inc

  • $65.9 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 04, 2022
BUY
$1.32 - $3.76 $8,448 - $24,064
6,400 Added 49.23%
19,400 $26,000
Q2 2022

Aug 15, 2022
BUY
$2.15 - $8.4 $27,950 - $109,200
13,000 New
13,000 $30,000

Others Institutions Holding HSTO

# of Institutions
1
Shares Held
17
Call Options Held
0
Put Options Held
0
View Full List

About Histogen Inc.

HSTO Quotes by TradingView
  • Ticker HSTO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,497,450
  • Market Cap $524K
  • Description
  • Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. It offers HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; HST-004, a cell conditioned media...
More about HSTO
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email